Unraveling the oncogenic role of LINC00504 and its interaction with miR-545-3p and ARIHI in hepatocellular carcinoma: novel insights for molecular therapy
This study uncovers the significant tumor-suppressing role of LINC00504 in HCC, potentially through a mechanism involving the targeting of miR-545-3p, which in turn inhibits the ARIH1. These findings offer new potential targets for HCC molecular treatment.
Authors
- Eugene Ke (ORCID: https://orcid.org/0000-0002-6369-5802)
- Kai Yang (ORCID: https://orcid.org/0000-0002-1982-4398)
- Qin Zhang (ORCID: https://orcid.org/0000-0002-4597-7697)
- Hai Zhang (ORCID: https://orcid.org/0000-0002-8705-6351)
- Junhua Wang (ORCID: https://orcid.org/0000-0002-6110-3711)
- Zhiyong Hu (ORCID: https://orcid.org/0000-0002-9082-3056)
- Cheng Luo (ORCID: https://orcid.org/0000-0001-7214-9195)
Institutions
- Huangshi Central Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1007/s12672-025-02328-2
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00